Narrow search
Showing 1 - 10 of 37
Cover Image
A certolizumab pegol kezelés rheumatoid arthritisben, irodalmi áttekintés és egészség-gazdaságtani elemzés = Certolizumab pegol in patients with rheumatoid arthritis: systematic re...
Gulácsi, László; Brodszky, Valentin; Péntek, Márta; … - 2009
Persistent link: https://www.econbiz.de/10010124491
Cover Image
Systematic review and analysis of evidences on clinical efficacy and cost-effectiveness of biological drugs for the treatment of rheumatoid arthritis
Péntek, Márta; Baji, Petra; Brodszky, Valentin; … - 2014
Persistent link: https://www.econbiz.de/10010434928
Cover Image
A prosztatarák gazdasági terhe nagy betegregiszterek alapján (The economic burden of prostate cancer. A systematic literature overview of registry-based studies)
Rencz, Fanni; Brodszky, Valentin; Varga, Péter; … - 2014
INTRODUCTION: Prostate cancer, the most frequent malignant disease in males in Europe, accounts for a great proportion of health expenditures. AIM: A systematic review of registry-based studies about the cost-of-illness and related factors of prostate cancer, published in the last 10 years....
Persistent link: https://www.econbiz.de/10010434936
Cover Image
Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis.
Baji, Petra; Péntek, Márta; Szántó, Sándor; … - 2014
mixed treatment comparison) was carried out. The proportion of patients reaching 20 % improvement by the assessment of … reported for week 12 in 12 RCTs involving 2,395 patients, and for week 24 in 5 RCTs comprising 1,337 patients. All the five …
Persistent link: https://www.econbiz.de/10010434939
Cover Image
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison.
Baji, Petra; Péntek, Márta; Czirjak, László; … - 2014
OBJECTIVE: The aim of this meta-analysis was to compare the efficacy and safety of infliximab-biosimilar and other available biologicals for the treatment of rheumatoid arthritis (RA), namely abatacept, adalimumab, certolizumab pegol, etanercept, golimumab, infliximab, rituximab and tocilizumab....
Persistent link: https://www.econbiz.de/10010434940
Cover Image
The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?
Baji, Petra; Péntek, Márta; Boncz, Imre; Brodszky, … - 2015
In the past few years, several papers have been published in the international literature on the impact of the economic crisis on health and health care. However, there is limited knowledge on this topic regarding the Central and Eastern European (CEE) countries. The main aims of this study are...
Persistent link: https://www.econbiz.de/10011287964
Cover Image
The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?
Baji, Petra; Péntek, Márta; Boncz, Imre; Brodszky, … - 2015
In the past few years, several papers have been published in the international literature on the impact of the economic crisis on health and health care. However, there is limited knowledge on this topic regarding the Central and Eastern European (CEE) countries. The main aims of this study are...
Persistent link: https://www.econbiz.de/10011287993